Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIIb Study Minimizing Adverse Haemmhorragic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)

NCT01433627 is registered in ClinicalTrials.gov with Italian Society of Invasive Cardiology as lead sponsor.

NCT NCT01433627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01433627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIIb Study Minimizing Adverse Haemmhorragic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)
Lead sponsor
Italian Society of Invasive Cardiology
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2011
Completion date
December 31, 2015
Enrollment
7,200 (estimated)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, nstemi, stemi